Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:FLRAFOTCMKTS:FPLSFOTCMKTS:IQEPFOTCMKTS:OXBDF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFLRAFEssentra$1.36$1.37$1.36▼$2.42$390.01M-0.5625 shsN/AFPLSF5N Plus$6.33+1.2%$5.60$2.00▼$7.00$556.76M1.8412,122 shs5,924 shsIQEPFIQE$0.14$0.13$0.10▼$0.44$139.38M1.5710 shsN/AOXBDFOxford BioMedica$4.28$4.14$3.15▼$5.68$453.12M1.14444 shsN/AThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFLRAFEssentra0.00%-0.73%-0.73%-5.56%-43.80%FPLSF5N Plus0.00%-7.80%+5.95%+79.11%+44.70%IQEPFIQE0.00%0.00%+0.14%-1.17%-54.23%OXBDFOxford BioMedica0.00%-8.23%+8.91%+21.14%+4.30%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFLRAFEssentraN/AN/AN/AN/AN/AN/AN/AN/AFPLSF5N Plus0.6729 of 5 stars0.03.00.00.03.00.00.6IQEPFIQEN/AN/AN/AN/AN/AN/AN/AN/AOXBDFOxford BioMedicaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFLRAFEssentra 3.00BuyN/AN/AFPLSF5N Plus 0.00N/AN/AN/AIQEPFIQE 0.00N/AN/AN/AOXBDFOxford BioMedica 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IQEPF, FLRAF, FPLSF, and OXBDF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2025FLRAFEssentraDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFLRAFEssentra$386.45M1.01$0.22 per share6.06$1.21 per share1.12FPLSF5N Plus$289.28M1.95$0.40 per share15.71$1.56 per share4.06IQEPFIQE$143.40M0.97N/AN/A$0.26 per share0.55OXBDFOxford BioMedica$111.34M4.07N/AN/A$1.01 per share4.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFLRAFEssentra$13.55MN/A0.00∞N/AN/AN/AN/A7/29/2025 (Estimated)FPLSF5N Plus$14.67M$0.2426.37∞N/A6.94%18.49%6.92%8/4/2025 (Estimated)IQEPFIQE-$36.54MN/A0.00∞N/AN/AN/AN/A9/8/2025 (Estimated)OXBDFOxford BioMedica-$195.90MN/A0.00N/AN/AN/AN/AN/AN/ALatest IQEPF, FLRAF, FPLSF, and OXBDF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025FPLSF5N Plus$0.0560$0.12+$0.0640$0.11$73.56 million$88.89 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFLRAFEssentraN/AN/AN/AN/AN/AFPLSF5N PlusN/AN/AN/AN/AN/AIQEPFIQEN/AN/AN/AN/AN/AOXBDFOxford BioMedicaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFLRAFEssentra0.472.281.34FPLSF5N Plus0.813.541.48IQEPFIQEN/AN/AN/AOXBDFOxford BioMedicaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFLRAFEssentraN/AFPLSF5N Plus0.06%IQEPFIQEN/AOXBDFOxford BioMedicaN/AInsider OwnershipCompanyInsider OwnershipFLRAFEssentraN/AFPLSF5N Plus3.94%IQEPFIQEN/AOXBDFOxford BioMedicaN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFLRAFEssentra3,000286.77 millionN/ANot OptionableFPLSF5N Plus78089.07 million85.56 millionNot OptionableIQEPFIQE685971.28 millionN/ANot OptionableOXBDFOxford BioMedica891105.96 millionN/ANot OptionableIQEPF, FLRAF, FPLSF, and OXBDF HeadlinesRecent News About These CompaniesOxford BioMedica completes purchase of last 10% stake in US subsidiaryJune 23 at 8:12 AM | lse.co.ukOxford BioMedica (OTCMKTS:OXBDF) Trading Down 8.2% - What's Next?June 20 at 12:43 AM | marketbeat.comOxford BioMedica touts strong first-half momentum ahead of meetingJune 11, 2025 | lse.co.ukOxford Biomedica (OTCMKTS:OXBDF) Trading 18.7% Higher - Here's What HappenedJune 1, 2025 | marketbeat.comOxford Biomedica Full Year 2024 Earnings: EPS Beats ExpectationsMay 1, 2025 | finance.yahoo.comOxford BioMedica (OXBDF) Receives a Buy from RBC CapitalApril 15, 2025 | theglobeandmail.comWhen Will Oxford Biomedica plc (LON:OXB) Turn A Profit?April 10, 2025 | uk.finance.yahoo.comOxford Biomedica sees FY25 revenue GBP 160M-GBP 170MApril 9, 2025 | msn.comOxford Biomedica prepares statements on ‘going concern basis’April 9, 2025 | msn.comOxford Biomedica plc (OXBDF) Q4 2024 Earnings Call TranscriptApril 9, 2025 | seekingalpha.comOxford Biomedica annual loss narrows; hails "commercial momentum"April 9, 2025 | lse.co.ukOxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trialFebruary 20, 2025 | markets.businessinsider.comOxford Biomedica appoints joint corporate broker, joint financial advisorFebruary 5, 2025 | markets.businessinsider.comOxford Biomedica Announces Total Voting Rights for 2024January 2, 2025 | markets.businessinsider.comOxford Biomedica Announces Total Voting RightsDecember 2, 2024 | markets.businessinsider.comOxford Biomedica Aligns Executive Incentives with GoalsNovember 23, 2024 | markets.businessinsider.comSanofi hands back gene therapies to Oxford BiomedicaNovember 15, 2024 | pharmaphorum.comOxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorganOctober 29, 2024 | markets.businessinsider.comOxford Biomedica Seeks Stock Market ExpansionOctober 22, 2024 | markets.businessinsider.comRBC Capital Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)September 27, 2024 | markets.businessinsider.comOxford BioMedica: A Strong Buy on Undervaluation and Promising Growth ProspectsSeptember 24, 2024 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIQEPF, FLRAF, FPLSF, and OXBDF Company DescriptionsEssentra OTCMKTS:FLRAF$1.36 0.00 (0.00%) As of 06/20/2025Essentra plc manufactures and distributes plastic injection and vinyl dip moulded, and metal components worldwide. The company offers cable ties and conduit, and accessories; grommets, strain relief, and blanking plugs; cable glands and accessories; caps and plugs; card guides and pullers; circuit board hardware products; EMI suppression ferrite cores; fan accessories comprising filters and fan mounting accessories; screws and nuts; rivet and panel fasteners; washers; spacers; brushes; fleet; fibre management; and furniture fittings. It also provides gasketing, toggle clamps, and enclosure accessories; handles, knobs, and positioning components; masking tapes, hooks, and bags; hose clamps, O-rings and O-ring kits, and hose protection products; LED mounting, light pipes and lens; LED spacers; locks, latches, catches, and hinges; pipe and flange protection essentra products; tube inserts, connectors, and ferrules; and vibration mounts, dampers, and slide bearings, as well as handwheels. The company offers its products for a range of applications and industries that are used in protection and finish products. The company was formerly known as Filtrona plc and changed its name to Essentra plc in June 2013. Essentra plc was incorporated in 2005 and is based in Oxford, the United Kingdom.5N Plus OTCMKTS:FPLSF$6.33 +0.08 (+1.23%) As of 01:37 PM Eastern5N Plus Inc. produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells. It also provides active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, engineered powders, and recycling services. The company serves renewable energy, security, space, pharmaceutical, medical imaging, manufacturing, electronic, consumer, and industrial application markets. 5N Plus Inc. is headquartered in Montreal, Canada.IQE OTCMKTS:IQEPF$0.14 0.00 (0.00%) As of 06/20/2025IQE plc, together with its subsidiaries, develops, manufactures, and sells advanced semiconductor materials. It operates through three segments: Wireless, Photonics, and CMOS++. The company manufactures and sells compound semiconductor materials for the wireless market which includes radio frequency devices for wireless communications, and photonics market, that includes applications that transmit and sense visible and infrared lights, as well as advanced semiconductor materials related to silicon. It operates in the United States, rest of the Americas, France, Germany, Israel, the United Kingdom, rest of Europe, the Middle East, Africa, the People's Republic of China, Japan, Taiwan, and rest of the Asia-Pacific. The company was founded in 1988 and is headquartered in Cardiff, the United Kingdom.Oxford BioMedica OTCMKTS:OXBDF$4.28 0.00 (0.00%) As of 06/20/2025Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
